CoChat

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

Xin Yang, Rong Yin, Lin Xu · 2018 · New England Journal of Medicine

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmc1808251

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 8 references

Cited by

See all 291

Metadata

Authors
Yang, X., Yin, R., & Xu, L.
Affiliations
  • The First People's Hospital of Changzhou (CN)
  • Jiangsu Cancer Hospital (CN)
Venue
New England Journal of Medicine
Published
2018-08-30
Volume
379
Issue
9
Pages
e14-e14
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2982617740
Cited by
277
References
8
Citations by year
2026: 3 · 2025: 11 · 2024: 25 · 2023: 65 · 2022: 40 · 2021: 49 · 2020: 49 · 2019: 28 · 2018: 7
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
Keywords
neoadjuvant immunotherapy, anti-PD-1 therapy, lung cancer, resectable non-small cell lung cancer, immune checkpoint inhibitors, surgical resection
MeSH terms
Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms, Pancreatic Neoplasms, Neoadjuvant Therapy, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neoadjuvant PD-1 Blockade in Resectable Lung Cancer. https://app.cochat.ai/papers/10.1056/nejmc1808251
The paper
Yang, X., Yin, R., & Xu, L. (2018). Neoadjuvant PD-1 Blockade in Resectable Lung Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmc1808251

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.